Hans-Martin Blickensdoerfer - Sep 7, 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Sr. VP, Comm. Ops, China
Signature
/s/ Samuel Gesten as attorney-in-fact for Hans Blickensdoerfer
Stock symbol
STAA
Transactions as of
Sep 7, 2021
Transactions value $
-$5,478,244
Form type
4
Date filed
9/9/2021, 04:03 PM
Previous filing
Sep 3, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Sale -$1.81M -11.5K -12.99% $157.40 77.2K Sep 7, 2021 Direct F1
transaction STAA Common Stock Options Exercise $505K +14K +18.17% $35.98 91.2K Sep 7, 2021 Direct
transaction STAA Common Stock Options Exercise $416K +15.1K +16.55% $27.53 106K Sep 7, 2021 Direct
transaction STAA Common Stock Sale -$4.59M -29.1K -27.4% $157.40 77.2K Sep 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 -14K -77.35% $0.00 4.11K Sep 7, 2021 Common Stock 14K $35.98 Direct F3
transaction STAA Common Stock Options Options Exercise $0 -15.1K -47.22% $0.00 16.9K Sep 7, 2021 Common Stock 15.1K $27.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive.
F3 The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.
F4 The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the next 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.